首页>
外国专利>
SGK1 INHIBITORS IN THE TREATMENT OF LONG QT SYNDROME
SGK1 INHIBITORS IN THE TREATMENT OF LONG QT SYNDROME
展开▼
机译:SGK1抑制剂治疗长QT综合征
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the treatment of acquired and genetic heart conditions in a subject by the inhibition of SGK1, including Long QT syndrome and cardiovascular disease, including dilated cardiomyopathy. Cardiovascular diseases treatable by SGK1 inhibition include heart failure, arrhythmia, ischemic injury, ischemic infarction, cardiac fibrosis, vascular proliferation, restenosis, dilated cardiomyopathy, and stent failure. The present invention also identifies selective inhibitors of SGK1. The method comprises administering to the subject a therapeutically effective amount of an inhibitor of SG.
展开▼